By collaborating with Accenture on this comprehensive BPM initiative, the pharmaceutical company has taken major strides toward achieving its goal of process standardization and overall operational cost reduction. The BPM governance organization the company established with Accenture’s help is operating smoothly and providing the crucial support for process improvement activities and decision making, while the process repository has driven increased compliance and internal process controls, it supports the training of employees on new process changes, and reduces risk in process execution.
As future BPM initiatives are undertaken, the company anticipates achieving even greater benefits. For instance, Process Monitoring and Control capability that can further boost process efficiency and transparency; a BPM managed services function that can enable faster turnaround of operations utilizing work across global time zones; and Process Value Analysis that can help the company undertake future BPM-related initiatives that have the highest value with a direct bearing on the company’s strategic objectives and goals, including cost reduction, global standardization, and performance improvement.
While the pharmaceutical industry has never been more challenging, they have at their disposal ever-more powerful solutions such as BPM that can help them respond to the challenges they face. Indeed, by working with Accenture this company is positioning itself to compete more effectively today and in the future while making greater strides toward high performance.